News programs
Oct 31

As part of the grant provided to scientists awarded the Cancer Research Foundation Young Investigator Award, awardees agree to present their research to the Foundation's Board of Directors in a series of short presentations.  These talks do a good job of showing all of the different types of ideas and fields of study that the Cancer Research Foundation brings to bear on cancer science.  This year's speakers discuss a wide variety for research topics, from the effect of using off-label drugs on the state of clinical trials to the possibility of using proteins to promote the death of cancer cells.

Here are the presentations from 2012 Young Investigators:

David G. DeNardo, PhD - 2012 Young Investigator Award

"Targeting Cancer Stem Cells By Modulating Immune Responses"

James L. LaBelle, MD, PhD - 2012 Young Investigator Award

"Defining the Mechanism and Therapeutic Targets of BIM BH3-Mediated Cell Death in Diffuse Large B-cell Lymphoma"

Hongtao Liu, MD, PhD - 2012 Young Investigator Award

"Prophylactic Donor Lymphocyte Infusion after T Cell Depleted Allogeneic Stem Cell Transplant In High Risk Patients With Hematologic Malignancies"

Manish R. Sharma, MD - 2012 Young Investigator Award

"Disease Progression Models for Biomarkers and Patient-Reported Outcomes in Cancer Patients"

Fabrice Smieliauskas, PhD - 2012 Young Investigator Award

"Off-Label Drug Use in Oncology: Policy, Unintended Consequences and Comparative Effectiveness"